Why CEOs need advanced education and training for optimizing decisions in the development of innovative medicinal products? justification and recommendation
Crossref DOI link: https://doi.org/10.3389/fphar.2024.1480338
Published Online: 2024-12-18
Update policy: https://doi.org/10.3389/crossmark-policy
Kramer, Peter-Jürgen
Bode, Gerd
Bass, Rolf
Version of Record valid from 2024-12-18
